Honore, P. M., Mugisha, A., Kugener, L., Redant, S., Attou, R., Gallerani, A., & De Bels, D. (2020). The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: Is moderate ARDS the best indication for neuromuscular blocking agents. Crit Care.

Honore, Patrick M., Aude Mugisha, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, and David De Bels. "The Use of a Neuromuscular Blocking Agent Could Significantly Decrease Mortality in Moderate-to-severe ARDS Patients: Is Moderate ARDS the Best Indication for Neuromuscular Blocking Agents." Crit Care 2020.

Honore, Patrick M., et al. "The Use of a Neuromuscular Blocking Agent Could Significantly Decrease Mortality in Moderate-to-severe ARDS Patients: Is Moderate ARDS the Best Indication for Neuromuscular Blocking Agents." Crit Care 2020.